Six-month-old Xiao Zhang (a pseudonym) is lying in her mother’s arms, watching cartoon characters on TV with great interest, and doesn’t look at all strange. If it wasn’t for the doctor’s reminder that there was a surgical wound the size of a green bean on the right side of her neck, you might not have thought that she had just undergone heart surgery treatment a day earlier. Previously, heart surgery always gave people the feeling of high risk and trauma, and the general surgical scars were greater than 10cm, some even 20cm or more. Even most of the current minimally invasive cardiac surgery, the surgical scars are between 4-6cm, and there are more than one, more than 3 or 4. Surprisingly, Xiao Zhang only had a 0.3cm, almost negligible surgical wound. Xiao Zhang underwent the latest minimally invasive transcervical heart defect closure surgery at the First Hospital of Guangzhou Medical University. As the first hospital in China to perform this technique, it has so far operated on more than 20 children with congenital heart disease, with a success rate of more than 95 percent. Xiao Zhang, who has a congenital atrial septal defect, is not suitable for medical interventional surgery due to his age and weight restrictions. Conventional cardiac surgery would have required open-heart surgery and extracorporeal circulation. Not only are the surgical incisions large and the scars obvious, but also the surgical risks are relatively high. After continuous technical improvement, transcervical minimally invasive heart defect closure surgery has become quite mature and can be widely used to treat most of the atrial septal defects and ventricular septal defects, and it is basically not limited by age and weight, without radiation, with few postoperative complications and sequelae; compared with traditional cardiac surgery, it is aesthetically pleasing, less traumatic, faster recovery, lower risk, and no significant increase in hospitalization cost, which is essential for saving the lives of It is of great significance to save the lives of many patients with precordial heart disease and reduce the pain and risk of surgery. Xie Shaobo, director of the Department of Cardiac Surgery at the First Hospital of Guangzhou Medical University, is a renowned expert in minimally invasive cardiac surgery in China, and the first person to perform transjugular minimally invasive heart defect closure surgery, which has been demonstrated abroad on behalf of China with unprecedented success and has received unanimous recognition from experts at home and abroad. In addition to transcervical minimally invasive heart defect sealing surgery, Director Xie Shaobo has high attainments in transthoracic minimally invasive heart surgery and thoracoscopic valve surgery, which have saved the lives of many heart patients.